Pieris napi chromosome 17, ilPieNapi1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Papilionoidea; Pieridae; Pierinae; Pieris.
REFSEQ INFORMATION: The reference sequence is identical to\nFR997711.1.\nAssembly name: ilPieNapi1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/01/30. The original whole-genome shotgun project has the\naccession CAJQFT000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Pieris napi Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
eukaryotic translation initiation factor 4 gamma 2
MOB kinase activator-like 2, transcript variant X1
MOB kinase activator-like 2, transcript variant X3
MOB kinase activator-like 2, transcript variant X2
tyrosine-protein phosphatase 10D-like, transcript variant X2
tyrosine-protein phosphatase 10D-like, transcript variant X1
caseinolytic peptidase B protein homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
caseinolytic peptidase B protein homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
caseinolytic peptidase B protein homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
caseinolytic peptidase B protein homolog
transient receptor potential-gamma protein-like, transcript variant X2
transient receptor potential-gamma protein-like, transcript variant X1
transient receptor potential-gamma protein-like, transcript variant X3
transient receptor potential-gamma protein-like isoform X2
transient receptor potential-gamma protein-like isoform X1
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X2
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X1
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X3
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog isoform X1
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog isoform X2
double-strand break repair protein MRE11
uncharacterized protein KIAA0930 homolog, transcript variant X2
uncharacterized protein KIAA0930 homolog, transcript variant X7
uncharacterized protein KIAA0930 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein KIAA0930 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC125058060 isoform X2
uncharacterized protein KIAA0930 homolog isoform X6
uncharacterized protein LOC125058060 isoform X1
uncharacterized protein KIAA0930 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphatidylcholine:ceramide cholinephosphotransferase 2-like
uncharacterized protein KIAA0930 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein KIAA0930 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
probable phospholipid-transporting ATPase IA, transcript variant X5
probable phospholipid-transporting ATPase IA, transcript variant X8
probable phospholipid-transporting ATPase IA, transcript variant X1
probable phospholipid-transporting ATPase IA, transcript variant X3
probable phospholipid-transporting ATPase IA, transcript variant X2
probable phospholipid-transporting ATPase IA, transcript variant X7
probable phospholipid-transporting ATPase IA, transcript variant X4
probable phospholipid-transporting ATPase IA isoform X5
probable phospholipid-transporting ATPase IA isoform X8
probable phospholipid-transporting ATPase IA isoform X1
probable phospholipid-transporting ATPase IA isoform X3
probable phospholipid-transporting ATPase IA isoform X2
probable phospholipid-transporting ATPase IA isoform X7
probable phospholipid-transporting ATPase IA isoform X4
probable phospholipid-transporting ATPase IA, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable phospholipid-transporting ATPase IA, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable phospholipid-transporting ATPase IA isoform X10
probable phospholipid-transporting ATPase IA isoform X9
probable phospholipid-transporting ATPase IA, transcript variant X6
probable phospholipid-transporting ATPase IA isoform X6
cholinephosphotransferase 1, transcript variant X5
cholinephosphotransferase 1, transcript variant X6
cholinephosphotransferase 1, transcript variant X1
cholinephosphotransferase 1, transcript variant X2
cholinephosphotransferase 1, transcript variant X3
cholinephosphotransferase 1, transcript variant X4
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X3
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X4
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11, transcript variant X1
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X3
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X4
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X2
ankyrin repeat and BTB/POZ domain-containing protein BTBD11 isoform X1
balbiani ring protein 3-like, transcript variant X1
balbiani ring protein 3-like, transcript variant X2
uncharacterized protein LOC125058084 isoform X2
zinc finger protein 721, transcript variant X1
zinc finger protein 721, transcript variant X2
uncharacterized protein LOC125057775 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
N-acetylgalactosaminyltransferase 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TBC1 domain family member 19, transcript variant X2
TBC1 domain family member 19, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TBC1 domain family member 19, transcript variant X1
TBC1 domain family member 19, transcript variant X3
alkylated DNA repair protein alkB homolog 8, transcript variant X1
alkylated DNA repair protein alkB homolog 8, transcript variant X2
alkylated DNA repair protein alkB homolog 8 isoform X1
alkylated DNA repair protein alkB homolog 8 isoform X2
phosphatidylinositol N-acetylglucosaminyltransferase subunit A
clathrin light chain, transcript variant X1
clathrin light chain, transcript variant X2
growth arrest and DNA damage-inducible proteins-interacting protein 1
nitric oxide synthase-interacting protein homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 146 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 46
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 76 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 154 samples with support for all annotated introns
hemicentin-1-like, transcript variant X2
hemicentin-1-like, transcript variant X4
hemicentin-1-like, transcript variant X1
hemicentin-1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 81 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
low-density lipoprotein receptor-related protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
dolichyl-phosphate beta-glucosyltransferase
programmed cell death protein 6, transcript variant X2
programmed cell death protein 6, transcript variant X1
programmed cell death protein 6, transcript variant X3
programmed cell death protein 6 isoform X1
programmed cell death protein 6 isoform X2
7-methylguanosine phosphate-specific 5'-nucleotidase
phospholipid-transporting ATPase VD, transcript variant X1
phospholipid-transporting ATPase VD, transcript variant X2
phospholipid-transporting ATPase VD isoform X1
phospholipid-transporting ATPase VD isoform X2
beta-alanine-activating enzyme, transcript variant X1
beta-alanine-activating enzyme isoform X1
beta-alanine-activating enzyme, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 96 samples with support for all annotated introns
beta-alanine-activating enzyme, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
beta-alanine-activating enzyme isoform X3
beta-alanine-activating enzyme isoform X2
beta-alanine-activating enzyme, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
beta-alanine-activating enzyme isoform X4
protein kinase C-binding protein NELL1-like
uncharacterized LOC125057951, transcript variant X2
uncharacterized LOC125057951, transcript variant X1
CD151 antigen-like, transcript variant X3
CD151 antigen-like, transcript variant X1
CD151 antigen-like, transcript variant X2
leukocyte surface antigen CD53-like isoform X1
leukocyte surface antigen CD53-like isoform X2
POC1 centriolar protein homolog A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
POC1 centriolar protein homolog A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
POC1 centriolar protein homolog A-like isoform X1
POC1 centriolar protein homolog A-like isoform X2
transfer RNA proline (anticodon AGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
rab proteins geranylgeranyltransferase component A 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
probable serine/threonine-protein kinase clkA
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
tetratricopeptide repeat protein 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
tetratricopeptide repeat protein 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
post-GPI attachment to proteins factor 2-like
protein scalloped, transcript variant X1
protein scalloped, transcript variant X2
protein scalloped, transcript variant X3
transcriptional enhancer factor TEF-1 isoform X2
transcriptional enhancer factor TEF-1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 80% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
lysosomal acid glucosylceramidase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
lysosomal acid glucosylceramidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
lysosomal acid glucosylceramidase-like isoform X1
lysosomal acid glucosylceramidase-like isoform X2
mitochondrial inner membrane protease subunit 1
zinc transporter 1, transcript variant X1
zinc transporter 1, transcript variant X2
zinc/cadmium resistance protein isoform X1
glutamate receptor ionotropic, delta-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
glutamate receptor ionotropic, delta-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glutamate receptor ionotropic, delta-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
glutamate receptor ionotropic, delta-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
glutamate receptor ionotropic, delta-2-like isoform X1
glutamate receptor ionotropic, delta-2-like isoform X2
glutamate receptor ionotropic, delta-2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC125058034 isoform X3
histone deacetylase complex subunit SAP30 homolog
high mobility group protein DSP1-like, transcript variant X1
high mobility group protein DSP1-like isoform X1
high mobility group protein DSP1-like, transcript variant X2
high mobility group protein DSP1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC125057743, transcript variant X1
uncharacterized LOC125057743, transcript variant X3
uncharacterized LOC125057743, transcript variant X2
uncharacterized protein LOC125057743 isoform X1
uncharacterized protein LOC125057743 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
gastrula zinc finger protein XlCGF17.1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 161 samples with support for all annotated introns
zinc finger protein ehn-3, transcript variant X2
zinc finger protein ehn-3, transcript variant X1
zinc finger protein ehn-3, transcript variant X3
testis-specific serine/threonine-protein kinase 3-like, transcript variant X6
testis-specific serine/threonine-protein kinase 3-like, transcript variant X3
testis-specific serine/threonine-protein kinase 3-like isoform X3
testis-specific serine/threonine-protein kinase 3-like isoform X6
testis-specific serine/threonine-protein kinase 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
testis-specific serine/threonine-protein kinase 3-like, transcript variant X4
testis-specific serine/threonine-protein kinase 1-like isoform X2
testis-specific serine/threonine-protein kinase 1-like isoform X4
testis-specific serine/threonine-protein kinase 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
testis-specific serine/threonine-protein kinase 1-like isoform X1
testis-specific serine/threonine-protein kinase 3-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
testis-specific serine/threonine-protein kinase 1-like isoform X5
ER degradation-enhancing alpha-mannosidase-like protein 2
tumor necrosis factor receptor superfamily member wengen
transmembrane protein 41 homolog, transcript variant X1
transmembrane protein 41 homolog, transcript variant X2
transmembrane protein 41 homolog isoform X1
transmembrane protein 41 homolog isoform X2
metacaspase-2-like, transcript variant X1
metacaspase-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC125057737, transcript variant X2
uncharacterized LOC125057737, transcript variant X1
uncharacterized LOC125057737, transcript variant X3
uncharacterized protein LOC125057737 isoform X1
uncharacterized protein LOC125057737 isoform X2
uncharacterized protein LOC125057737 isoform X3
uncharacterized LOC125057678, transcript variant X1
uncharacterized LOC125057678, transcript variant X2
monocarboxylate transporter 13-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
monocarboxylate transporter 13-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
monocarboxylate transporter 1-like isoform X1
monocarboxylate transporter 13-like isoform X2
facilitated trehalose transporter Tret1-like, transcript variant X1
facilitated trehalose transporter Tret1-like isoform X1
facilitated trehalose transporter Tret1-like, transcript variant X2
facilitated trehalose transporter Tret1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 107 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein yellow-like
proton-coupled amino acid transporter-like protein pathetic
NADH-cytochrome b5 reductase 2, transcript variant X2
NADH-cytochrome b5 reductase 2 isoform X2
NADH-cytochrome b5 reductase 2, transcript variant X3
NADH-cytochrome b5 reductase 2 isoform X3
NADH-cytochrome b5 reductase 2, transcript variant X1
NADH-cytochrome b5 reductase 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
LIM domain only protein 3, transcript variant X1
LIM domain only protein 3, transcript variant X2
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
histidine--tRNA ligase, cytoplasmic, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 486 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
histidine--tRNA ligase, cytoplasmic, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 484 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 118 samples with support for all annotated introns
histidine--tRNA ligase, cytoplasmic, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 488 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
histidine--tRNA ligase, cytoplasmic isoform X3
histidine--tRNA ligase, cytoplasmic isoform X1
histidine--tRNA ligase, cytoplasmic isoform X2
vacuolar protein-sorting-associated protein 36, transcript variant X1
vacuolar protein-sorting-associated protein 36, transcript variant X2
vacuolar protein-sorting-associated protein 36
vacuolar ATPase assembly integral membrane protein VMA21 homolog
uncharacterized LOC125057890, transcript variant X1
uncharacterized LOC125057890, transcript variant X2
uncharacterized protein LOC125057890 isoform X1
uncharacterized protein LOC125057890 isoform X2
glutamine-dependent NAD(+) synthetase, transcript variant X1
glutamine-dependent NAD(+) synthetase, transcript variant X2
glutamine-dependent NAD(+) synthetase, transcript variant X3
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC125058011, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC125058011, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
uncharacterized protein LOC125058011 isoform X1
uncharacterized protein LOC125058011 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
inactive angiotensin-converting enzyme-related protein-like, transcript variant X3
inactive angiotensin-converting enzyme-related protein-like, transcript variant X1
inactive angiotensin-converting enzyme-related protein-like, transcript variant X2
inactive angiotensin-converting enzyme-related protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
DNA-directed RNA polymerase I subunit RPA12
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
peripheral plasma membrane protein CASK, transcript variant X1
peripheral plasma membrane protein CASK, transcript variant X3
peripheral plasma membrane protein CASK, transcript variant X4
peripheral plasma membrane protein CASK, transcript variant X2
peripheral plasma membrane protein CASK, transcript variant X6
peripheral plasma membrane protein CASK, transcript variant X5
peripheral plasma membrane protein CASK isoform X1
peripheral plasma membrane protein CASK isoform X3
peripheral plasma membrane protein CASK isoform X4
peripheral plasma membrane protein CASK isoform X2
peripheral plasma membrane protein CASK isoform X6
peripheral plasma membrane protein CASK isoform X5
uncharacterized LOC125057961, transcript variant X2
uncharacterized LOC125057961, transcript variant X1
uncharacterized LOC125057961, transcript variant X3
uncharacterized LOC125057961, transcript variant X4
uncharacterized protein LOC125057961 isoform X2
uncharacterized protein LOC125057961 isoform X1
uncharacterized protein LOC125057961 isoform X4
uncharacterized protein LOC125057961 isoform X3
vacuolar protein sorting-associated protein 72 homolog
uncharacterized LOC125057694, transcript variant X2
uncharacterized LOC125057694, transcript variant X1
uncharacterized protein LOC125057694 isoform X1
uncharacterized protein LOC125057694 isoform X2
uncharacterized LOC125057695, transcript variant X2
uncharacterized LOC125057695, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
probable sodium/potassium-transporting ATPase subunit beta-3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial, transcript variant X2
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial, transcript variant X1
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial isoform X1
probable 2-oxoglutarate dehydrogenase E1 component DHKTD1 homolog, mitochondrial isoform X2
transmembrane protein 135-like, transcript variant X1
transmembrane protein 135-like, transcript variant X2
transmembrane protein 135-like isoform X1
transmembrane protein 135-like isoform X2
CCR4-NOT transcription complex subunit 6, transcript variant X1
CCR4-NOT transcription complex subunit 6, transcript variant X2
CCR4-NOT transcription complex subunit 6 isoform X1
CCR4-NOT transcription complex subunit 6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
28S ribosomal protein S24, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 135 samples with support for all annotated introns
uncharacterized LOC125057975, transcript variant X1
uncharacterized LOC125057975, transcript variant X2
uncharacterized protein LOC125057975 isoform X1
uncharacterized protein LOC125057975 isoform X2
fibril-forming collagen alpha chain-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
glucose transporter type 1-like, transcript variant X1
glucose transporter type 1-like, transcript variant X4
glucose transporter type 1-like, transcript variant X5
glucose transporter type 1-like, transcript variant X2
glucose transporter type 1-like, transcript variant X3
glucose transporter type 1-like, transcript variant X6
glucose transporter type 1-like isoform X1
glucose transporter type 1-like isoform X2
glucose transporter type 1-like isoform X3
cationic trypsin-3-like, transcript variant X2
cationic trypsin-3-like, transcript variant X1
transmembrane protease serine 9-like, transcript variant X2
transmembrane protease serine 9-like isoform X2
transmembrane protease serine 9-like, transcript variant X1
transmembrane protease serine 9-like isoform X1
putative thiamine transporter SLC35F3, transcript variant X4
putative thiamine transporter SLC35F3, transcript variant X1
putative thiamine transporter SLC35F3, transcript variant X3
putative thiamine transporter SLC35F3, transcript variant X2
putative thiamine transporter SLC35F3 isoform X3
putative thiamine transporter SLC35F3 isoform X2
putative thiamine transporter SLC35F3 isoform X4
putative thiamine transporter SLC35F3 isoform X1
ankyrin repeat domain-containing protein 17, transcript variant X1
ankyrin repeat domain-containing protein 17, transcript variant X5
ankyrin repeat domain-containing protein 17, transcript variant X3
ankyrin repeat domain-containing protein 17, transcript variant X4
ankyrin repeat domain-containing protein 17, transcript variant X6
ankyrin repeat domain-containing protein 17, transcript variant X2
ankyrin repeat domain-containing protein 17 isoform X1
ankyrin repeat domain-containing protein 17 isoform X5
ankyrin repeat domain-containing protein 17 isoform X4
ankyrin repeat domain-containing protein 17 isoform X3
ankyrin repeat domain-containing protein 17 isoform X6
ankyrin repeat domain-containing protein 17 isoform X2
ankyrin repeat domain-containing protein 17, transcript variant X7
ankyrin repeat domain-containing protein 17 isoform X7
alpha-2-macroglobulin receptor-associated protein, transcript variant X2
alpha-2-macroglobulin receptor-associated protein, transcript variant X1
alpha-2-macroglobulin receptor-associated protein isoform X2
alpha-2-macroglobulin receptor-associated protein isoform X1
E3 ubiquitin-protein ligase RNF19A-like, transcript variant X1
E3 ubiquitin-protein ligase RNF19A-like isoform X1
E3 ubiquitin-protein ligase RNF19A-like, transcript variant X2
E3 ubiquitin-protein ligase RNF19A-like isoform X2
RING finger and transmembrane domain-containing protein 2
ADP-ribosylation factor-like protein 6-interacting protein 4
thioredoxin domain-containing protein 5 homolog
valacyclovir hydrolase, transcript variant X1
valacyclovir hydrolase, transcript variant X2
tolloid-like protein 2, transcript variant X3
tolloid-like protein 2, transcript variant X1
tolloid-like protein 2, transcript variant X2
tolloid-like protein 2, transcript variant X4
heterogeneous nuclear ribonucleoprotein R, transcript variant X5
heterogeneous nuclear ribonucleoprotein R, transcript variant X4
heterogeneous nuclear ribonucleoprotein R, transcript variant X2
heterogeneous nuclear ribonucleoprotein R, transcript variant X6
heterogeneous nuclear ribonucleoprotein R, transcript variant X1
heterogeneous nuclear ribonucleoprotein R, transcript variant X10
heterogeneous nuclear ribonucleoprotein R, transcript variant X9
heterogeneous nuclear ribonucleoprotein R, transcript variant X7
heterogeneous nuclear ribonucleoprotein R, transcript variant X3
heterogeneous nuclear ribonucleoprotein R, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 82 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R isoform X2
heterogeneous nuclear ribonucleoprotein R isoform X7
heterogeneous nuclear ribonucleoprotein R isoform X3
heterogeneous nuclear ribonucleoprotein R isoform X6
heterogeneous nuclear ribonucleoprotein R isoform X4
heterogeneous nuclear ribonucleoprotein R isoform X1
heterogeneous nuclear ribonucleoprotein R isoform X10
heterogeneous nuclear ribonucleoprotein R, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R isoform X5
heterogeneous nuclear ribonucleoprotein R, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein R isoform X11
heterogeneous nuclear ribonucleoprotein R isoform X9
heterogeneous nuclear ribonucleoprotein R isoform X8
ER membrane protein complex subunit 1, transcript variant X1
ER membrane protein complex subunit 1, transcript variant X2
ER membrane protein complex subunit 1 isoform X1
ER membrane protein complex subunit 1 isoform X2
TELO2-interacting protein 1 homolog, transcript variant X1
TELO2-interacting protein 1 homolog, transcript variant X2
TELO2-interacting protein 1 homolog isoform X2
TELO2-interacting protein 1 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cysteine proteinase B-like, transcript variant X2
cysteine proteinase B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC125057715, transcript variant X2
uncharacterized protein LOC125057715 isoform X2
uncharacterized LOC125057715, transcript variant X1
uncharacterized protein LOC125057715 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 104 samples with support for all annotated introns
BPTI/Kunitz domain-containing protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC125057777, transcript variant X1
uncharacterized LOC125057777, transcript variant X2
uncharacterized protein LOC125057777 isoform X1
uncharacterized protein LOC125057777 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
facilitated trehalose transporter Tret1-like
glutamate receptor ionotropic, delta-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitochondrial pyruvate carrier 1, transcript variant X1
mitochondrial pyruvate carrier 1, transcript variant X2
mitochondrial pyruvate carrier 1, transcript variant X4
mitochondrial pyruvate carrier 1, transcript variant X5
mitochondrial pyruvate carrier 1, transcript variant X3
glutathione S-transferase 1-1-like, transcript variant X1
glutathione S-transferase 1-1-like, transcript variant X2
WD repeat-containing protein 44, transcript variant X1
WD repeat-containing protein 44, transcript variant X2
WD repeat-containing protein 44, transcript variant X3
WD repeat-containing protein 44, transcript variant X4
WD repeat-containing protein 44, transcript variant X6
WD repeat-containing protein 44, transcript variant X5
WD repeat-containing protein 44, transcript variant X7
WD repeat-containing protein 44, transcript variant X8
WD repeat-containing protein 44, transcript variant X9
WD repeat-containing protein 44, transcript variant X10
WD repeat-containing protein 44 isoform X1
WD repeat-containing protein 44 isoform X2
WD repeat-containing protein 44 isoform X5
WD repeat-containing protein 44 isoform X7
WD repeat-containing protein 44 isoform X9
WD repeat-containing protein 44 isoform X3
WD repeat-containing protein 44 isoform X8
WD repeat-containing protein 44 isoform X10
WD repeat-containing protein 44 isoform X4
WD repeat-containing protein 44 isoform X6
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
trafficking protein particle complex subunit 1
mitochondrial import inner membrane translocase subunit Tim17-B
epidermal growth factor receptor substrate 15 homolog, transcript variant X1
epidermal growth factor receptor substrate 15 homolog, transcript variant X2
epidermal growth factor receptor substrate 15 homolog isoform X2
epidermal growth factor receptor substrate 15 homolog, transcript variant X5
epidermal growth factor receptor substrate 15 homolog, transcript variant X6
epidermal growth factor receptor substrate 15 homolog, transcript variant X3
epidermal growth factor receptor substrate 15 homolog isoform X3
epidermal growth factor receptor substrate 15 homolog isoform X5
epidermal growth factor receptor substrate 15 homolog, transcript variant X7
epidermal growth factor receptor substrate 15 homolog isoform X6
epidermal growth factor receptor substrate 15 homolog, transcript variant X4
epidermal growth factor receptor substrate 15 homolog isoform X4
fragile X mental retardation syndrome-related protein 1, transcript variant X3
fragile X mental retardation syndrome-related protein 1, transcript variant X2
fragile X mental retardation syndrome-related protein 1, transcript variant X1
fragile X mental retardation syndrome-related protein 1 homolog A isoform X3
fragile X mental retardation syndrome-related protein 1 isoform X2
fragile X mental retardation syndrome-related protein 1 isoform X1
GDP-L-fucose synthase, transcript variant X2
GDP-L-fucose synthase, transcript variant X4
GDP-L-fucose synthase, transcript variant X1
GDP-L-fucose synthase, transcript variant X5
GDP-L-fucose synthase, transcript variant X3
glutamate dehydrogenase, mitochondrial-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: glutamate dehydrogenase, mitochondrial-like
phenylalanine--tRNA ligase alpha subunit
saccharopine dehydrogenase-like oxidoreductase, transcript variant X1
saccharopine dehydrogenase-like oxidoreductase, transcript variant X2
saccharopine dehydrogenase-like oxidoreductase
saccharopine dehydrogenase-like oxidoreductase isoform X1
saccharopine dehydrogenase-like oxidoreductase, transcript variant X3
saccharopine dehydrogenase-like oxidoreductase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
pyruvate dehydrogenase E1 component subunit beta, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
collagen alpha chain CG42342, transcript variant X7
collagen alpha chain CG42342, transcript variant X1
collagen alpha chain CG42342, transcript variant X6
collagen alpha chain CG42342, transcript variant X8
collagen alpha chain CG42342, transcript variant X3
collagen alpha chain CG42342, transcript variant X4
collagen alpha chain CG42342, transcript variant X2
collagen alpha chain CG42342, transcript variant X5
collagen alpha chain CG42342, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 93 samples with support for all annotated introns
(E3-independent) E2 ubiquitin-conjugating enzyme, transcript variant X2
(E3-independent) E2 ubiquitin-conjugating enzyme, transcript variant X1
(E3-independent) E2 ubiquitin-conjugating enzyme isoform X1
(E3-independent) E2 ubiquitin-conjugating enzyme isoform X2
ecdysone oxidase-like, transcript variant X1
ecdysone oxidase-like, transcript variant X3
ecdysone oxidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125057875, transcript variant X2
uncharacterized LOC125057875, transcript variant X1
uncharacterized protein LOC125057875 isoform X2
uncharacterized protein LOC125057875 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 105 samples with support for all annotated introns
uncharacterized LOC125057922, transcript variant X1
uncharacterized LOC125057922, transcript variant X2
uncharacterized LOC125057917, transcript variant X3
uncharacterized LOC125057917, transcript variant X1
uncharacterized LOC125057917, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
facilitated trehalose transporter Tret1-like, transcript variant X3
facilitated trehalose transporter Tret1-like, transcript variant X4
facilitated trehalose transporter Tret1-like isoform X3
facilitated trehalose transporter Tret1-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
facilitated trehalose transporter Tret1-like, transcript variant X5
facilitated trehalose transporter Tret1-like, transcript variant X6
glucose transporter GlcP-like isoform X5
solute carrier family 2, facilitated glucose transporter member 6-like isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 143 samples with support for all annotated introns
eukaryotic translation initiation factor 3 subunit D
E3 ubiquitin-protein ligase SIAH1-like, transcript variant X4
E3 ubiquitin-protein ligase SIAH1-like, transcript variant X1
E3 ubiquitin-protein ligase SIAH1-like, transcript variant X2
E3 ubiquitin-protein ligase SIAH1-like, transcript variant X3
E3 ubiquitin-protein ligase SIAH1-like isoform X1
E3 ubiquitin-protein ligase SIAH1-like isoform X2
uncharacterized LOC125057929, transcript variant X1
uncharacterized LOC125057929, transcript variant X2
signal recognition particle subunit SRP68
signal recognition particle subunit SRP68-like
E3 ubiquitin-protein ligase ZNF598, transcript variant X2
E3 ubiquitin-protein ligase ZNF598, transcript variant X1
E3 ubiquitin-protein ligase ZNF598 isoform X2
E3 ubiquitin-protein ligase ZNF598 isoform X1
protein abnormal spindle, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
protein abnormal spindle, transcript variant X2
carboxypeptidase N subunit 2-like, transcript variant X2
carboxypeptidase N subunit 2-like, transcript variant X1
carboxypeptidase N subunit 2-like isoform X2
carboxypeptidase N subunit 2-like isoform X1
WD repeat-containing protein 3, transcript variant X2
WD repeat-containing protein 3, transcript variant X1
WD repeat-containing protein 3 isoform X2
WD repeat-containing protein 3 isoform X1
lethal(2) giant larvae protein, transcript variant X2
lethal(2) giant larvae protein, transcript variant X3
lethal(2) giant larvae protein, transcript variant X5
lethal(2) giant larvae protein, transcript variant X1
lethal(2) giant larvae protein homolog 1 isoform X3
lethal(2) giant larvae protein homolog 1 isoform X1
lethal(2) giant larvae protein homolog 1 isoform X2
lethal(2) giant larvae protein isoform X5
lethal(2) giant larvae protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
lethal(2) giant larvae protein isoform X4
thrombospondin type-1 domain-containing protein 7A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC125057724, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC125057724, transcript variant X2
uncharacterized protein LOC125057724 isoform X1
uncharacterized protein LOC125057724 isoform X2
serine/arginine-rich splicing factor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
serine/arginine-rich splicing factor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
serine/arginine-rich splicing factor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
serine/arginine-rich splicing factor 2 isoform X1
serine/arginine-rich splicing factor 2 isoform X2
INO80 complex subunit C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
U3 small nucleolar RNA-interacting protein 2
INO80 complex subunit C, transcript variant X2
INO80 complex subunit C, transcript variant X3
ribosome biogenesis regulatory protein homolog
DNA fragmentation factor subunit beta, transcript variant X1
DNA fragmentation factor subunit beta isoform X1
DNA fragmentation factor subunit beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
DNA fragmentation factor subunit beta isoform X2
dual specificity mitogen-activated protein kinase kinase 6
transmembrane protein 94, transcript variant X3
transmembrane protein 94, transcript variant X1
transmembrane protein 94, transcript variant X2
transmembrane protein 94, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
WASH complex subunit 1-like, transcript variant X6
WASH complex subunit 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
WASH complex subunit 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 96 samples with support for all annotated introns
WASH complex subunit 1-like, transcript variant X7
WASH complex subunit 1-like, transcript variant X9
WASH complex subunit 1-like, transcript variant X5
WASH complex subunit 1-like, transcript variant X4
WASH complex subunit 1-like, transcript variant X8
WASH complex subunit 1-like, transcript variant X3
WASH complex subunit 1-like, transcript variant X10
uncharacterized LOC125057696, transcript variant X3
uncharacterized LOC125057696, transcript variant X1
uncharacterized LOC125057696, transcript variant X2
uncharacterized LOC125057696, transcript variant X4
uncharacterized protein LOC125057696 isoform X2
uncharacterized protein LOC125057696 isoform X3
uncharacterized protein LOC125057696 isoform X4
uncharacterized protein LOC125057696 isoform X1
ribonuclease Z, mitochondrial, transcript variant X1
ribonuclease Z, mitochondrial, transcript variant X7
ribonuclease Z, mitochondrial, transcript variant X3
ribonuclease Z, mitochondrial, transcript variant X5
ribonuclease Z, mitochondrial, transcript variant X10
ribonuclease Z, mitochondrial, transcript variant X12
ribonuclease Z, mitochondrial, transcript variant X14
ribonuclease Z, mitochondrial, transcript variant X4
ribonuclease Z, mitochondrial, transcript variant X11
ribonuclease Z, mitochondrial, transcript variant X13
ribonuclease Z, mitochondrial, transcript variant X15
ribonuclease Z, mitochondrial, transcript variant X2
ribonuclease Z, mitochondrial, transcript variant X6
ribonuclease Z, mitochondrial, transcript variant X8
ribonuclease Z, mitochondrial, transcript variant X9
ribonuclease Z, mitochondrial isoform X1
ribonuclease Z, mitochondrial isoform X5
ribonuclease Z, mitochondrial isoform X9
ribonuclease Z, mitochondrial isoform X11
ribonuclease Z, mitochondrial isoform X13
ribonuclease Z, mitochondrial isoform X4
ribonuclease Z, mitochondrial isoform X10
ribonuclease Z, mitochondrial isoform X12
ribonuclease Z, mitochondrial isoform X14
ribonuclease Z, mitochondrial isoform X2
ribonuclease Z, mitochondrial isoform X6
ribonuclease Z, mitochondrial isoform X7
ribonuclease Z, mitochondrial isoform X3
ribonuclease Z, mitochondrial isoform X8
26S proteasome non-ATPase regulatory subunit 4
putative ATP synthase subunit f, mitochondrial
mesencephalic astrocyte-derived neurotrophic factor homolog, transcript variant X2
mesencephalic astrocyte-derived neurotrophic factor homolog, transcript variant X1
mesencephalic astrocyte-derived neurotrophic factor homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
leucine-rich repeat and death domain-containing protein 1-like, transcript variant X1
leucine-rich repeat and death domain-containing protein 1-like, transcript variant X2
leucine-rich repeat and death domain-containing protein 1-like, transcript variant X3
leucine-rich repeat protein soc-2 homolog isoform X1
uncharacterized protein LOC125057844 isoform X3
leucine-rich repeat and death domain-containing protein 1-like isoform X2
cancer-related nucleoside-triphosphatase homolog
probable enoyl-CoA hydratase, mitochondrial, transcript variant X2
probable enoyl-CoA hydratase, mitochondrial, transcript variant X1
probable enoyl-CoA hydratase, mitochondrial isoform X2
probable enoyl-CoA hydratase, mitochondrial isoform X1
uncharacterized LOC125058019, transcript variant X2
uncharacterized LOC125058019, transcript variant X1
uncharacterized protein LOC125058019 isoform X1
uncharacterized protein LOC125058019 isoform X2
glutaminyl-peptide cyclotransferase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 141 samples with support for all annotated introns
glutaminyl-peptide cyclotransferase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 159 samples with support for all annotated introns
glutaminyl-peptide cyclotransferase-like isoform X2
glutaminyl-peptide cyclotransferase-like isoform X3
glutaminyl-peptide cyclotransferase-like, transcript variant X1
glutaminyl-peptide cyclotransferase-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
N-acylneuraminate cytidylyltransferase A
UPF0193 protein EVG1 homolog, transcript variant X1
UPF0193 protein EVG1 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
RING finger protein unkempt, transcript variant X3
RING finger protein unkempt, transcript variant X2
RING finger protein unkempt, transcript variant X1
uncharacterized LOC125057998, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125057998, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
uncharacterized protein LOC125057998 isoform X2
uncharacterized protein LOC125057998 isoform X1
cyclin-dependent kinase 2-associated protein 1-like, transcript variant X1
cyclin-dependent kinase 2-associated protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
cyclin-dependent kinase 2-associated protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
cyclin-dependent kinase 2-associated protein 1-like isoform X3
diphthine methyltransferase-like isoform X1
diphthine methyltransferase-like isoform X2
uncharacterized protein CG5098-like, transcript variant X2
uncharacterized protein CG5098-like, transcript variant X3
uncharacterized protein CG5098-like, transcript variant X4
uncharacterized protein CG5098-like, transcript variant X1
uncharacterized protein CG5098-like isoform X2
uncharacterized protein CG5098-like isoform X3
uncharacterized protein CG5098-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
acylamino-acid-releasing enzyme-like, transcript variant X2
acylamino-acid-releasing enzyme-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 89 samples with support for all annotated introns
acylamino-acid-releasing enzyme-like, transcript variant X1
acylamino-acid-releasing enzyme-like isoform X1
acylamino-acid-releasing enzyme-like isoform X2
acylamino-acid-releasing enzyme-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone]-like, transcript variant X2
glucose dehydrogenase [FAD, quinone]-like, transcript variant X1
glucose dehydrogenase [FAD, quinone]-like isoform X2
glucose dehydrogenase [FAD, quinone]-like isoform X1
geranylgeranyl transferase type-2 subunit beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125057759, transcript variant X2
uncharacterized LOC125057759, transcript variant X1
uncharacterized LOC125057760, transcript variant X1
uncharacterized LOC125057760, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
rho GDP-dissociation inhibitor 1, transcript variant X1
rho GDP-dissociation inhibitor 1, transcript variant X2
rho GDP-dissociation inhibitor 1 isoform X1
rho GDP-dissociation inhibitor 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125057798, transcript variant X1
uncharacterized LOC125057798, transcript variant X3
uncharacterized LOC125057798, transcript variant X2
uncharacterized protein LOC125057798 isoform X1
uncharacterized protein LOC125057798 isoform X2
uncharacterized protein LOC125057798 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
guanine nucleotide-binding protein subunit gamma-e
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
myosin heavy chain, non-muscle, transcript variant X2
myosin heavy chain, non-muscle, transcript variant X1
myosin heavy chain, non-muscle isoform X2
myosin heavy chain, non-muscle isoform X1
myosin heavy chain, non-muscle, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
myosin heavy chain, non-muscle isoform X3
probable low-specificity L-threonine aldolase 2, transcript variant X4
probable low-specificity L-threonine aldolase 2, transcript variant X3
probable low-specificity L-threonine aldolase 2, transcript variant X2
probable low-specificity L-threonine aldolase 2, transcript variant X1
probable low-specificity L-threonine aldolase 2
transmembrane channel-like protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 121 samples with support for all annotated introns
transmembrane channel-like protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
transmembrane channel-like protein 7 isoform X1
transmembrane channel-like protein 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
transmembrane channel-like protein 5 isoform X2
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized protein K02A2.6-like, transcript variant X3
uncharacterized protein K02A2.6-like, transcript variant X1
uncharacterized protein K02A2.6-like, transcript variant X2
uncharacterized protein K02A2.6-like isoform X1
uncharacterized protein LOC125057692 isoform X3
uncharacterized protein K02A2.6-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 121 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 82 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87% coverage of the annotated genomic feature by RNAseq alignments
protein ALP1-like, transcript variant X1
protein ALP1-like, transcript variant X2
macrophage mannose receptor 1-like, transcript variant X2
macrophage mannose receptor 1-like, transcript variant X1
macrophage mannose receptor 1-like isoform X1
uncharacterized protein LOC125057829 isoform X2
oxidized purine nucleoside triphosphate hydrolase-like
peptidyl-tRNA hydrolase ICT1, mitochondrial
clusterin-associated protein 1, transcript variant X1
clusterin-associated protein 1, transcript variant X2
clusterin-associated protein 1 isoform X1
clusterin-associated protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125057810, transcript variant X1
uncharacterized LOC125057810, transcript variant X3
uncharacterized LOC125057810, transcript variant X2
uncharacterized LOC125057810, transcript variant X4
uncharacterized protein LOC125057810 isoform X1
uncharacterized protein LOC125057810 isoform X2
uncharacterized protein LOC125057810 isoform X3
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X2
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X1
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like
vacuolar protein sorting-associated protein 41 homolog, transcript variant X2
vacuolar protein sorting-associated protein 41 homolog isoform X2
vacuolar protein sorting-associated protein 41 homolog, transcript variant X1
vacuolar protein sorting-associated protein 41 homolog isoform X1
regulatory-associated protein of mTOR, transcript variant X1
regulatory-associated protein of mTOR, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
enoyl-CoA hydratase domain-containing protein 2, mitochondrial
NAD-dependent protein deacetylase sirtuin-7
28S ribosomal protein S33, mitochondrial
N-sulphoglucosamine sulphohydrolase, transcript variant X1
N-sulphoglucosamine sulphohydrolase, transcript variant X2
N-sulphoglucosamine sulphohydrolase isoform X1
N-sulphoglucosamine sulphohydrolase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments